Cidara Therapeutics Inc buy melinda
Start price
21.03.18
/
50%
€5.01
Target price
21.09.18
€7.31
Performance (%)
-25.23%
End price
21.09.18
€3.74
Summary
This prediction ended on 21.09.18 with a price of €3.74. The prediction for Cidara Therapeutics Inc disappointed with a performance of -25.23%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Cidara Therapeutics Inc | - | - | - | - |
iShares Core DAX® | 1.280% | 1.320% | 13.605% | 15.782% |
iShares Nasdaq 100 | -2.457% | -5.192% | 25.941% | 38.434% |
iShares Nikkei 225® | -2.006% | -1.389% | 8.973% | 6.570% |
iShares S&P 500 | -0.662% | -1.884% | 23.684% | 39.611% |
Comments by melinda for this prediction
In the thread Cidara Therapeutics Inc diskutieren
Biotechnologie und medizinische SecteurRecherche
Cidara Therapeutics, Inc.
Cidara Therapeutics stellt aktualisierte klinische Daten für seine Anti - Pilz - Blei rézafungine
(Laufzeit überschritten)
Stopped prediction by melinda for Cidara Therapeutics Inc
Cidara Therapeutics Inc
Start price
Target price
Perf. (%)
€2.41
31.03.19
31.03.19
€2.71
04.11.21
04.11.21
-31.57%
22.06.21
22.06.21
Cidara Therapeutics Inc
Start price
Target price
Perf. (%)
€9.59
19.03.16
19.03.16
€13.53
13.04.16
13.04.16
41.58%
13.04.16
13.04.16